|
|
Volumn 29, Issue 6, 1999, Pages 1408-1410
|
|
Editorial response: Estimating the true cost of amphotericin B
a
a
1728 JFB
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B LIPID COMPLEX;
AMPHOTERICIN B-DEOXYCHOLATE;
ANTIFUNGAL AGENT;
DEOXYCHOLIC ACID;
PHOSPHATIDYLCHOLINE;
PHOSPHATIDYLGLYCEROL;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG TOLERABILITY;
EDITORIAL;
MYCOSIS;
NEPHROTOXICITY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
CHEMISTRY;
DRUG COMBINATION;
ECONOMICS;
HUMAN;
NOTE;
AMPHOTERICIN B;
ANTIBIOTICS, ANTIFUNGAL;
COST-BENEFIT ANALYSIS;
DEOXYCHOLIC ACID;
DRUG COMBINATIONS;
HUMANS;
PHOSPHATIDYLCHOLINES;
PHOSPHATIDYLGLYCEROLS;
|
|
EID: 0033258517
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/313555 Document Type: Editorial |
|
Times cited : (40)
|
|
References (18)
|
